The Best Growth Stocks by Revenue & Profit

Stocks with high revenue and earnings growth on a TTM basis, ranked by distance from the 52-week high.
Rank Stock Price Rev. Gr. Dist.
52WH
Perf. 20D
WKN | Symbol EPS Growth Rel. Strength
1 Verisk Analytics 278.09 $ 26.37 % 9.32 % -3.45 %
A0YA2M | VRSK 88.86 % 86
2 Palomar Holdings 130.13 $ 40.22 % 9.49 % -0.24 %
A2PHB6 | PLMR 49.48 % 96
3 HCI Group 137.14 $ 49.16 % 9.70 % -1.56 %
A1W02H | HCI 199.39 % 85
4 Progressive 259.68 $ 22.67 % 11.37 % -6.44 %
865496 | PGR 198.70 % 88
5 Universal Technical Institute 26.47 $ 20.63 % 13.39 % -1.64 %
590097 | UTI 533.33 % 96
6 Halozyme Therapeutics 56.53 $ 21.35 % 14.34 % -7.15 %
A0DLHS | HALO 60.73 % 92
7 Insulet 246.49 $ 27.42 % 14.84 % -0.76 %
A0MQX8 | PODD 250.00 % 92
8 Interdigital 192.19 $ 28.53 % 17.15 % -9.55 %
A0MWY3 | IDCC 41.33 % 98
9 Tradeweb Markets 122.34 $ 29.44 % 19.86 % -8.22 %
TW 20.69 % 84
10 Catalyst Pharmaceuticals 20.86 $ 32.17 % 20.27 % -1.62 %
A0LCUL | CPRX 111.86 % 90
Subscribe now to see the full ranking

Already a subscriber? Login

Image 1Image 2Image 3Image 4Image 5
Sample Issue
$ 0
one issue
Bestseller
Trial Subscription
$ 33
1 month
Martin Springman

Business drivers: The US biotech company Halozyme Therapeutics (HALO) specializes in products related to proprietary enzyme technology. The ENHANZE technology developed by Halozyme allows for the subcutaneous administration of biological and medicinal substances, which offers significant advantages compared to traditional intramuscular or intravenous...